Fulminant hepatic failure following low-dose sustained-release niacin therapy in hospital.
PubMedPublished 1 October 1991Open access
Doron Fischer, Lisa Knight, Robert E. Vestal
Citations17
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
The case of a patient, admitted to hospital for a respiratory illness, in whom unexplained fulminant hepatic failure developed following treatment with 2 grams a day of niacin is reported, the first report of a fatality associated with low-dose SR niac in therapy.
Keywords
Medicine
Annals of Internal MedicineFulminant Hepatic Failure after Ingestion of Sustained-Release Nicotinic Acid
119 Citations1989Gerard E. Mullin, Joel K. Greenson +1 more
Nicotinic acid is an effective, widely used treatment for hypercholesterolemia and Hepatotoxicity is a rare complication of therapy, which usually occurs with ingestion of more than 3 g of the substance per day.
JAMANicotinic Acid Treatment of Hypercholesteremia
70 Citations1961Norman A. Christensen
The most significant difference was the greater frequency and severity of side effects during treatment with the 3 sustained-action preparations, and this precluded the majority of patients from completing a 3-month period of treatment.
JAMARechallenge With Crystalline Niacin After Drug-Induced Hepatitis From Sustained-Release Niacin
66 Citations1990Yaakov Henkin
Three patients who developed hepatitis during treatment with sustained-release niacin were rechallenged with equivalent or higher doses of crystalline niacIn, with no evidence of recurring hepatocellular damage.
Southern Medical JournalNiacin Hepatitis
45 Citations1983DAVID J. PATTERSON, EDWARD W. DEW +2 more
A case of severe liver injury occurring on two occasions in a patient ingesting large doses of nicotinic acid, with both massive and submassive lobular collapse and marked cholestasis is reported.
JAMAAcute Hepatic Failure Associated With the Use of Low-Dose Sustained-Release Niacin
40 Citations1990Howard N. Hodis